The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
about
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySerine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancerRegulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesisVascular endothelial growth factor as an anti-angiogenic target for cancer therapyOverexpression of VEGF165b in podocytes reduces glomerular permeability.Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data.Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.Recombinant human VEGF165b inhibits experimental choroidal neovascularizationTherapeutic potential of manipulating VEGF splice isoforms in oncologyThe anti-angiogenic isoforms of VEGF in health and disease.The role of mRNA splicing in prostate cancer.VEGF-A165b is cytoprotective and antiangiogenic in the retinaInvestigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells.Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesityDo anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary taleBorrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoformsNew Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological ProcessGenetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcomaSpecific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization.Murine rVEGF164b, an inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction.The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapyDetection of VEGF-A(xxx)b isoforms in human tissuesVEGF spliced variants: possible role of anti-angiogenesis therapy.Alternative splicing of VEGFA, APP and NUMB genes in colorectal cancerBalance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertilityPost-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation.VEGFA splicing: divergent isoforms regulate spermatogonial stem cell maintenance.Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity.The role of VEGF 165b in pathophysiologyAssociation between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab.Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangiomaRecombinant human VEGF165b protein is an effective anti-cancer agent in mice.Promoting melanoma growth and metastasis by enhancing VEGF expressionVEGF-A splicing: the key to anti-angiogenic therapeutics?Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells.Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
P2860
Q27342809-DC12F7B0-DB6E-413D-B9AB-51AC9E8245AEQ28251240-342B1939-9C0C-4C21-9504-9DB30ABF8172Q28513991-D6E4CEA6-03E0-4402-AEB5-6410E167E511Q30455612-EE994BC3-54CA-4065-A95D-035A13D84029Q30497786-8D7B3022-9E28-4F32-87F1-BC8556FCAB32Q33520467-2EF9383C-6CA9-4690-B50E-2A0CC3C4B088Q33531554-8D3C7D1C-F14E-4E3D-A286-651D3CD395D8Q33541827-61686860-3B0B-4974-AB73-8951E9641894Q33888458-69F06848-4E9E-4F84-BE88-3E825A55C7EBQ33901839-DE4F15C0-69BD-40DF-AB68-5257C25905BAQ33922376-27D5DDE3-7EF1-4AFB-88B1-D44F8645864EQ34022623-C5FDA0F8-98C6-49B1-A85E-908DA66C5C56Q34210916-536DFDF6-B70B-4879-9327-F474A0048D29Q34244804-F1C8642F-8311-4D48-8300-5D13545AC57FQ34261539-DF81D00B-8F15-4B98-A773-FCAD16531C58Q34347768-E768DE3B-A8B0-4FD0-BD11-0F089CF52236Q34474159-6B6A0D72-1C14-448B-8FE6-BDAD3798D04EQ34628523-C8EA6039-6E49-440B-BFC1-53D5FF31D0EAQ34656053-0E294CC6-4E6D-4B1A-87A8-AF801C517050Q34675574-EA432E23-7ADE-43EB-A568-818F3730B2E1Q34792239-3201F209-E93F-4CEE-A0CE-31E25711615AQ34918179-0246571B-E011-4BFC-8457-A5E22E55EBC3Q35369677-78FAE2FA-1E7B-4F88-9B05-1D97DD53CFFEQ35692268-08A2A5F0-1342-4D5A-AF34-F758418E5239Q35780472-0BAE77B3-89A4-4E4E-B2A5-14014C28C581Q35885946-BAA7DA5A-3F0C-4C7C-BF07-261BAF045A04Q36398266-2DA6CA12-E247-4236-8A4D-BEE39C5C492AQ36436720-FD21BC93-F7CD-49F1-BCD3-C57010F99B93Q36498533-8F4E7D1B-0525-4AD8-B9D8-BCD36E70858DQ36542093-B4BCDD57-CCFB-4145-B670-B5E4F042AC60Q36700844-CB401F1E-1262-4C1C-9237-2EE4A215BB89Q36908121-9645E02F-4FCA-4402-BB79-7D1216A3BC62Q36932464-8E296BE0-DB4F-4C2A-816F-89B2F25F1761Q36942659-859886AB-67B9-4871-928C-502887D91BCDQ37035757-F6C0C89D-7FC6-4C3C-AF7F-964127FA691DQ37061808-17B09028-2197-4C70-8041-E5396095AE31Q37083055-CABC2384-2F1D-462F-A6FA-5874AD528C26Q37149053-F46438DF-FD65-4F51-A0C3-A8CC3D4DE0BEQ37197773-BCDF230A-ABD2-4B1D-B972-BBBA1BD2C432Q37400534-1E6FEDB3-C692-4C55-BA63-03A6BB428A0F
P2860
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The endogenous anti-angiogenic ...... s human tumour growth in mice.
@ast
The endogenous anti-angiogenic ...... s human tumour growth in mice.
@en
type
label
The endogenous anti-angiogenic ...... s human tumour growth in mice.
@ast
The endogenous anti-angiogenic ...... s human tumour growth in mice.
@en
prefLabel
The endogenous anti-angiogenic ...... s human tumour growth in mice.
@ast
The endogenous anti-angiogenic ...... s human tumour growth in mice.
@en
P2093
P2860
P50
P356
P1476
The endogenous anti-angiogenic ...... ts human tumour growth in mice
@en
P2093
Es Kleinerman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604309
P407
P577
2008-03-18T00:00:00Z